FLUCLOXACILLIN Side Effects

6981467-1 | Coagulation Time Shortened, Embolic Stroke
on Aug 31, 2010 Female patient from IRELAND , 68 years of age, was diagnosed with soft tissue infection, atrial fibrillation (What is atrial fibrillation?) and was treated with Flucloxacillin (View Usage). Patient experienced the following unwanted or unexpected effects: coagulation time shortened, embolic stroke. Flucloxacillin dosage: . During the same period patient was treated with WARFARIN SODIUM (Doses Of 4 And 3mg On Alternate Days) (View Warfarin Sodium Review and Warfarin Sodium Label ), QUINAPRIL (View Quinapril Review and Quinapril Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), LERCANIDIPINE (View Lercanidipine Review and Lercanidipine Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), BUMETANIDE (View Bumetanide Review and Bumetanide Label ), DIGOXIN (View Digoxin Review and Digoxin Label ). Patient was hospitalized.

6445874-8 | Distal Intestinal Obstruction Syndrome
Patient was taking Flucloxacillin (View Usage). Patient had the following side effects: distal intestinal obstruction syndrome on Nov 05, 2009 from UNITED KINGDOM Additional patient health information: Female patient , 13 years of age, was diagnosed with prophylaxis, pancreatic insufficiency, medical diet, liver disorder and. Flucloxacillin dosage: Daily Dose: 2000 Milligram(s). During the same period patient was treated with CREON (View Creon Review and Creon Label ), VITAMIN K TAB (Daily Dose: 10 Milligram(s)) (View Vitamin K Tab Review and Vitamin K Tab Label ), VITAMIN E (Daily Dose: 75 International Unit(s)) (View Vitamin E Review and Vitamin E Label ), KETOVITE TABLETS (Daily Dose: 3 Dosage Form) (View Ketovite Tablets Review and Ketovite Tablets Label ), VITAMIN A+D (Daily Dose: 2 Dosage Form) (View Vitamin A+d Review and Vitamin A+d Label ), URSO 250 (Daily Dose: 600 Milligram(s)) (View Urso 250 Review and Urso 250 Label ). Patient was hospitalized.

6445873-6 | Distal Intestinal Obstruction Syndrome
Adverse event was reported on Nov 05, 2009 by a Female patient taking Flucloxacillin (View Usage) (Dosage: Daily Dose: 1000 Milligram(s)) was diagnosed with prophylaxis, pancreatic insufficiency, medical diet, wheezing, liver disorder and. Location: UNITED KINGDOM , 13 years of age, After Flucloxacillin was administered, patient had the following side effects: distal intestinal obstruction syndrome. During the same period patient was treated with CREON (View Creon Review and Creon Label ), VITAMIN K TAB (Daily Dose: 10 Milligram(s)) (View Vitamin K Tab Review and Vitamin K Tab Label ), VITAMIN E (Daily Dose: 75 International Unit(s)) (View Vitamin E Review and Vitamin E Label ), KETOVITE LIQIUD (Daily Dose: 5 Millilitre(s)) (View Ketovite Liqiud Review and Ketovite Liqiud Label ), KETOVITE TABLETS (Daily Dose: 3 Dosage Form) (View Ketovite Tablets Review and Ketovite Tablets Label ), OMEPRAZOLE (Daily Dose: 20 Milligram(s)) (View Omeprazole Review and Omeprazole Label ), SALBUTAMOL MDI (View Salbutamol Mdi Review and Salbutamol Mdi Label ), URSO 250 (Daily Dose: 750 Milligram(s)) (View Urso 250 Review and Urso 250 Label ). Patient was hospitalized.

6445872-4 | Distal Intestinal Obstruction Syndrome
on Nov 05, 2009 Female patient from UNITED KINGDOM , child 4 years of age, was diagnosed with prophylaxis, pancreatic insufficiency, medical diet and was treated with Flucloxacillin (View Usage). Patient experienced the following unwanted or unexpected effects: distal intestinal obstruction syndrome. Flucloxacillin dosage: Daily Dose: 750 Milligram(s). During the same period patient was treated with CREON (View Creon Review and Creon Label ), VITAMIN E (Daily Dose: 10 Milligram(s)) (View Vitamin E Review and Vitamin E Label ), VITAMIN K TAB (Daily Dose: 5 Milligram(s)) (View Vitamin K Tab Review and Vitamin K Tab Label ), DALIVIT (Daily Dose: 1.2 Millilitre(s)) (View Dalivit Review and Dalivit Label ). Patient was hospitalized.


6445871-2 | Distal Intestinal Obstruction Syndrome
on Nov 05, 2009 Female patient from UNITED KINGDOM , child 11 years of age, was diagnosed with prophylaxis, pancreatic insufficiency, medical diet, bronchospasm, asthma (What is asthma?) and was treated with Flucloxacillin (View Usage). Patient had the following side effects: distal intestinal obstruction syndrome. Flucloxacillin dosage: Daily Dose: 1500 Milligram(s). During the same period patient was treated with CREON (View Creon Review and Creon Label ), MENADIOL SOD DIPHOS (Daily Dose: 10 Milligram(s)) (View Menadiol Sod Diphos Review and Menadiol Sod Diphos Label ), VITAMIN E (Daily Dose: 75 International Unit(s)) (View Vitamin E Review and Vitamin E Label ), KETOVITE TABLETS (Daily Dose: 3 Dosage Form) (View Ketovite Tablets Review and Ketovite Tablets Label ), KETOVITE LIQUID (Daily Dose: 5 Millilitre(s)) (View Ketovite Liquid Review and Ketovite Liquid Label ), SALBUTAMOL INHALER (Daily Dose: 2 Dosage Form) (View Salbutamol Inhaler Review and Salbutamol Inhaler Label ), SALMETEROL + 250 FLUTICASONE INHALER (Daily Dose: 4 Dosage Form) (View Salmeterol + 250 Fluticasone Inhaler Review and Salmeterol + 250 Fluticasone Inhaler Label ). Patient was hospitalized.

6432541-X | International Normalised Ratio Decreased
Patient was taking Flucloxacillin (View Usage). After Flucloxacillin was administered, patient had the following side effects: international normalised ratio decreased on Oct 26, 2009 from NEW ZEALAND Additional patient health information: Male patient , 58 years of age, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and. Flucloxacillin dosage: . During the same period patient was treated with WARFARIN SODIUM (3mg And 4mg On Alternate Days) (View Warfarin Sodium Review and Warfarin Sodium Label ).

6073000-6 | Coagulation Time Prolonged, Confusional State, Haematuria, Melaena
Adverse event was reported on Feb 05, 2009 by a Male patient taking Flucloxacillin (View Usage) (Dosage: Unk) was diagnosed with abscess (What is abscess?), deep vein thrombosis (What is deep vein thrombosis?) and. Location: UNITED KINGDOM , 37 years of age, Patient experienced the following unwanted or unexpected effects: coagulation time prolonged, confusional state, haematuria, melaena. During the same period patient was treated with CLINDAMYCINE RANBAXY 300 MG CAPSULES (Unk) (View Clindamycine Ranbaxy 300 Mg Capsules Review and Clindamycine Ranbaxy 300 Mg Capsules Label ), WARFARIN SODIUM (4 Mg, Qd) (View Warfarin Sodium Review and Warfarin Sodium Label ).

5474779-4 | Blood Creatine Phosphokinase Increased, Rhabdomyolysis
on Sep 25, 2007 Male patient from UNITED KINGDOM , 45 years of age, was treated with Flucloxacillin (View Usage). Patient had the following side effects: blood creatine phosphokinase increased, rhabdomyolysis. Flucloxacillin dosage: . During the same period patient was treated with RANITIDINE (View Ranitidine Review and Ranitidine Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ). Patient was hospitalized.

5416742-5 | Blood Creatine Phosphokinase Increased, Rhabdomyolysis
on Aug 06, 2007 Male patient from UNITED KINGDOM , 45 years of age, was treated with Flucloxacillin (View Usage). After Flucloxacillin was administered, patient had the following side effects: blood creatine phosphokinase increased, rhabdomyolysis. Flucloxacillin dosage: . During the same period patient was treated with RANITIDINE (View Ranitidine Review and Ranitidine Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ). Patient was hospitalized.

5136734-3 | Activated Partial Thromboplastin Time Prolonged, Barrett's Oesophagus, Blood Albumin Decreased, Blood Amylase Increased, Blood Fibrinogen Increased, Coagulopathy, Depressed Level Of Consciousness, Empyema
Patient was taking Flucloxacillin (View Usage). Patient experienced the following unwanted or unexpected effects: activated partial thromboplastin time prolonged, barrett's oesophagus, blood albumin decreased, blood amylase increased, blood fibrinogen increased, coagulopathy, depressed level of consciousness, empyema on Oct 10, 2006 from INDIA Additional patient health information: Male patient , 50 years of age, was diagnosed with pyrexia, pain (What is pain?) and. Flucloxacillin dosage: 2 G, Qd, Intravenous; See Image. During the same period patient was treated with ACETAMINOPHEN (1 G, Q6h, Oral) (View Acetaminophen Review and Acetaminophen Label ), PHENYTOIN (View Phenytoin Review and Phenytoin Label ), PHENOBARBITAL TAB (View Phenobarbital Tab Review and Phenobarbital Tab Label ), CARBAMAZEPINE (View Carbamazepine Review and Carbamazepine Label ), CEFTRIAXONE (View Ceftriaxone Review and Ceftriaxone Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ), STREPTOKINASE (View Streptokinase Review and Streptokinase Label ), TIMENTIN (View Timentin Review and Timentin Label ). Patient was hospitalized.

4975966-1 | Jaundice Cholestatic
Adverse event was reported on Mar 31, 2006 by a Female patient taking Flucloxacillin (View Usage) (Dosage: 500 Mg, Qid, Oral) was diagnosed with cellulitis (What is cellulitis?) and. Location: UNITED KINGDOM , 91 years of age, Patient had the following side effects: jaundice cholestatic. During the same period patient was treated with AMOXICILLIN + CLAVULANATE POTASSIUM (375 Mg, Tid, Oral) (View Amoxicillin + Clavulanate Potassium Review and Amoxicillin + Clavulanate Potassium Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), BENDROFLUAZIDE (BENDROFLUMETHIAZIDE) (View Bendrofluazide (bendroflumethiazide) Review and Bendrofluazide (bendroflumethiazide) Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ). Patient was hospitalized.

4975966-1 | Jaundice Cholestatic
on Mar 31, 2006 Female patient from UNITED KINGDOM , 91 years of age, was diagnosed with cellulitis (What is cellulitis?) and was treated with Flucloxacillin (View Usage). After Flucloxacillin was administered, patient had the following side effects: jaundice cholestatic. Flucloxacillin dosage: 500 Mg, Qid, Oral. During the same period patient was treated with CO AMOXICLAV (AMOXICILLIN TRIHYDRATE) (375 Mg, Tid, Oral) (View Co-amoxiclav (amoxicillin Trihydrate) Review and Co-amoxiclav (amoxicillin Trihydrate) Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), BENDROFLUAZIDE (BENDROFLUMETHIAZIDE) (View Bendrofluazide (bendroflumethiazide) Review and Bendrofluazide (bendroflumethiazide) Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ). Patient was hospitalized.

4870705-7 | Hepatitis
on Dec 22, 2005 Male patient from UNITED KINGDOM , 77 years of age, weighting 180.8 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Flucloxacillin (View Usage). Patient experienced the following unwanted or unexpected effects: hepatitis (What is hepatitis?). Flucloxacillin dosage: . During the same period patient was treated with ROPINIROLE (1mg Three Times Per Day) (View Ropinirole Review and Ropinirole Label ).

4839122-X | Clostridium Colitis, Gastrointestinal Haemorrhage, Increased Viscosity Of Bronchial Secretion, Nausea
Patient was taking Flucloxacillin (View Usage). Patient had the following side effects: clostridium colitis, gastrointestinal haemorrhage, increased viscosity of bronchial secretion, nausea (What is nausea?) on Nov 24, 2005 from UNITED KINGDOM Additional patient health information: Male patient , 73 years of age, was diagnosed with cystitis escherichia, deep vein thrombosis (What is deep vein thrombosis?), oral candidiasis and. Flucloxacillin dosage: . During the same period patient was treated with AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ), CIPROFLOXACIN (500mg Twice Per Day) (View Ciprofloxacin Review and Ciprofloxacin Label ), TRIMETHOPRIM (200mg Twice Per Day) (View Trimethoprim Review and Trimethoprim Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), CO DYDRAMOL (2tab Four Times Per Day) (View Co-dydramol Review and Co-dydramol Label ), FERROUS SULFATE TAB (200mg Three Times Per Day) (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ), FLUCONAZOLE (200mg In The Morning) (View Fluconazole Review and Fluconazole Label ).

4694683-9 | Anaemia Haemolytic Autoimmune, Haematuria
Adverse event was reported on Jun 14, 2005 by a Female patient taking Flucloxacillin (View Usage) (Dosage: 500mg Per Day) was diagnosed with wound (What is wound?) and. Location: , 33 years of age, After Flucloxacillin was administered, patient had the following side effects: anaemia haemolytic autoimmune, haematuria. During the same period patient was treated with CEFOTETAN DISODIUM (1u Per Day) (View Cefotetan Disodium Review and Cefotetan Disodium Label ), AMOXICILLIN TRIHYDRATE (1.5g Per Day) (View Amoxicillin Trihydrate Review and Amoxicillin Trihydrate Label ), METRONIDAZOLE (1.5g Per Day) (View Metronidazole Review and Metronidazole Label ), VANCOMYCIN HYDROCHLORIDE (View Vancomycin Hydrochloride Review and Vancomycin Hydrochloride Label ).

4694681-5 | Haemolytic Anaemia
on Jun 14, 2005 Male patient from , weighting 6.61 lb, was diagnosed with congenital anomaly and was treated with Flucloxacillin (View Usage). Patient experienced the following unwanted or unexpected effects: haemolytic anaemia. Flucloxacillin dosage: 1g Per Day. During the same period patient was treated with SILVER SULPHADIAZINE (View Silver Sulphadiazine Review and Silver Sulphadiazine Label ), AMOXICILLIN TRIHYDRATE (325mg Per Day) (View Amoxicillin Trihydrate Review and Amoxicillin Trihydrate Label ), TOBRAMYCIN (21mg Per Day) (View Tobramycin Review and Tobramycin Label ).